Sensei Biotherapeutics, Inc.
USD13.85
-3.97 (-22.28%)
CEO
Christopher W. Gerry
IPO Date
2021-02-04
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$15.21
Prev. Close
$17.82
Day Low
$13.76
Day High
$16.52
52W Low
$6.33
52W High
$36.76
Market Cap
$0.02B
Volume
0.22M
| -8.2 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -52.5% | -45.9% | 0.10 | 11.92 | -11.3 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -47.0% | -41.0% | 0.08 | 11.98 | -18.8 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -25.1% | -24.0% | 0.02 | 30.38 | -87.4 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -126.5% | -93.8% | 0.04 | 4.16 | -575.2 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | 24.4% | -1375.5% | -0.23 | 0.02 | -662.2 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | 24.4% | -704.8% | -0.09 | 0.48 | -19.9 |
| -0.7 |
| 30 Sept 2025 | Q3 | 0.0% | 94.2% | -19.9% | -16.6% | 0.09 | 5.81 | -0.7 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -18.1% | -15.5% | 0.09 | 7.64 | -0.5 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -21.5% | -17.9% | 0.10 | 6.82 | -7.2 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -20.2% | -17.1% | 0.10 | 7.70 | -7.9 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -15.8% | -13.6% | 0.10 | 8.84 | -10.4 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -13.7% | -11.9% | 0.10 | 10.90 | -10.5 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -13.7% | -12.0% | 0.10 | 12.07 | -16.5 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -11.4% | -10.0% | 0.10 | 11.92 | -11.7 |